Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Esteva, Francisco
247  Ergebnisse:
Personensuche X
?
1

Long-term overall survival of patients who undergo breast-c..:

He, Xuexin ; Ji, Jiali ; Qdaisat, Aiham..
The Lancet Regional Health - Americas.  32 (2024)  - p. 100712 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Next-Generation HER2-Targeted Antibody–Drug Conjugates in B..:

Zimmerman, Brittney S. ; Esteva, Francisco J.
Cancers.  16 (2024)  4 - p. 800 , 2024
Link: https://doi.org/10.3390/..
 
?
3

A new paradigm for classifying and treating HER2‐positive b..:

He, Xuexin ; Yeung, Sai‐Ching J. ; Esteva, Francisco J.
Cancer Reports.  6 (2023)  8 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
4

Safety and impact of dose reductions on efficacy in the ran..:

Burris, Howard A. ; Chan, Arlene ; Bardia, Aditya...
British Journal of Cancer.  125 (2021)  5 - p. 679-686 , 2021
Link: https://doi.org/10.1038/..
 
?
5

Validation of plasma metabolites associated with breast can..:

Zhao, Hua ; Shen, Jie ; Ye, Yuanqing...
Cancer Epidemiology.  69 (2020)  - p. 101826 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Ribociclib plus fulvestrant for advanced breast cancer: Hea..:

Fasching, Peter A. ; Beck, J. Thaddeus ; Chan, Arlene...
The Breast.  54 (2020)  - p. 148-154 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Correction to: Breast cancer risk in relation to plasma met..:

Zhao, Hua ; Shen, Jie ; Moore, Steven C....
Breast Cancer Research and Treatment.  176 (2019)  3 - p. 697-697 , 2019
Link: https://doi.org/10.1007/..
 
?
8

Efficacy and safety of the combination of metformin, everol..:

Yam, Clinton ; Esteva, Francisco J. ; Patel, Miral M....
Investigational New Drugs.  37 (2019)  2 - p. 345-351 , 2019
Link: https://doi.org/10.1007/..
 
?
9

Breast cancer risk in relation to plasma metabolites among ..:

Zhao, Hua ; Shen, Jie ; Moore, Steven C....
Breast Cancer Research and Treatment.  176 (2019)  3 - p. 687-696 , 2019
Link: https://doi.org/10.1007/..
 
?
10

Are Biosimilars the Future of Oncology and Haematology?:

Zinzani, Pier Luigi ; Dreyling, Martin ; Gradishar, William...
Drugs.  79 (2019)  15 - p. 1609-1624 , 2019
Link: https://doi.org/10.1007/..
 
?
11

A plasma protein derived TGFβ signature is a prognostic ind..:

Katayama, Hiroyuki ; Tsou, Peiling ; Kobayashi, Makoto...
npj Precision Oncology.  3 (2019)  1 - p. , 2019
Link: https://doi.org/10.1038/..
 
?
12

Efficacy and Safety of Ribociclib With Letrozole in US Pati..:

Yardley, Denise A. ; Hart, Lowell ; Favret, Anne...
Clinical Breast Cancer.  19 (2019)  4 - p. 268-277.e1 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Prognostic role of elevated mir-24-3p in breast cancer and ..:

Khodadadi-Jamayran, Alireza ; Akgol-Oksuz, Betul ; Afanasyeva, Yelena...
Oncotarget.  9 (2018)  16 - p. 12868-12878 , 2018
Link: https://doi.org/10.18632..
 
?
14

First-line ribociclib plus letrozole in postmenopausal wome..:

Janni, Wolfgang ; Alba, Emilio ; Bachelot, Thomas...
Breast Cancer Research and Treatment.  169 (2018)  3 - p. 469-479 , 2018
Link: https://doi.org/10.1007/..
 
?
15

A phase II study of imatinib mesylate and letrozole in pati..:

Yam, Clinton ; Murthy, Rashmi K. ; Rauch, Gaiane M....
Investigational New Drugs.  36 (2018)  6 - p. 1103-1109 , 2018
Link: https://doi.org/10.1007/..
 
1-15